 | Up a level |
Number of items: 2.
Ramanan, AV, Hampson, LV, Lythgoe, H, Jones, AP, Hardwick, B, Hind, H, Jacobs, B, Vasileiou, D, Wadsworth, I, Ambrose, N et al (show 11 more authors)
(2019)
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.
PLOS ONE, 14 (6).
e0215739-.
Ambrose, N, Morgan, TA, Galloway, J, Ionnoau, Y, Beresford, MW 
ORCID: 0000-0002-5400-9911 and Isenberg, DA
(2016)
Differences in disease phenotype and severity in SLE across age groups.
LUPUS, 25 (14).
pp. 1542-1550.